865887-11-2 Usage
Uses
Used in Pharmaceutical Industry:
6-Benzyloxy-1H-indazole-3-carboxylic acid is used as a key intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its unique structure and functional groups allow for the creation of diverse drug candidates with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 6-Benzyloxy-1H-indazole-3-carboxylic acid is used as a building block for the creation of other complex organic compounds. Its presence of a benzyl ether and carboxylic acid group facilitates the formation of new chemical entities with potential applications in various industries.
Used in Drug Development:
6-Benzyloxy-1H-indazole-3-carboxylic acid is utilized in drug development as a starting material for the design and synthesis of new medications. Its structural features and reactivity make it a valuable component in the creation of compounds with potential therapeutic effects against various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 865887-11-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,5,8,8 and 7 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 865887-11:
(8*8)+(7*6)+(6*5)+(5*8)+(4*8)+(3*7)+(2*1)+(1*1)=232
232 % 10 = 2
So 865887-11-2 is a valid CAS Registry Number.
InChI:InChI=1/C15H12N2O3/c18-15(19)14-12-7-6-11(8-13(12)16-17-14)20-9-10-4-2-1-3-5-10/h1-8H,9H2,(H,16,17)(H,18,19)
865887-11-2Relevant articles and documents
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
-
Page/Page column 68, (2010/11/26)
The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF
-
Page/Page column 79, (2010/11/27)
The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of -disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
